Demographic and Clinical characteristics

MoA

(n = 25)

MA

(n = 10)

Chronic migraine
(n = 21)

TTH

(n = 4)

P1-value

P2-value

P3-value

P4-value
Male/female; #

9/16

2/8

8/13

1/3

-

-

-

-
Age; years

47.48 ± 8.43

49.87 ± 5.49

49.48 ± 6.10

48.55 ± 7.60

0.144

0.907

0.804

0.115
BMI; kg/m2

39.01 ± 6.05

36.64 ± 4.75

39.60 ± 5.23

28.55 ±6.56

0.050

0.0.54

0.012

0.133
Degree of obesity; # (%)
Normal: 18.5-24.9 kg/m2
Overweight: 25.0-29.9 kg/m2
Obese: 30.0-34.9 kg/m2
Morbidly obese: >35.0 kg/m2


0
2 (8%)
15 (60%)
13 (52%)


0
0
3 (30%)
7 (70%)


0
0
3 (14.29%)
18 (85.71%)


1 (1.67%)
3 (5%)
0
0


-
-
-
-


-
-
-
-


-
-
-
-

-
-
-
-

WC; cm

115.96 ± 8.84

116.20 ± 11.85

118.55 ± 5.67

108.36 ± 9.99

0.125

0.0.50

0.067

0.856
SBP; mmHg
DBP; mmHg

165.80 ± 10.18
100.20 ± 4.98

150.00 ± 13.54
95.33 ± 7.15

150.00 ± 13.33
95.20 ± 5.20

135.060 ± 16.33
80.20 ± 8.10

0.045
0.024

0.053
0.050

0.050
0.050

0.462
0.821
Duration of T2DM; years
Duration of overweight/obesity; years
Duration of HTN; years

5.92 ± 3.84
6.72 ± 3.18
4.60 ± 2.18

5.33 ± 3.59
10.53 ± 3.18
6.20 ± 3.86

10.67 ± 2.56
12.66 ± 3.56
10.78 ± 2.40

6.24 ± 2.50
5.04 ± 2.08
4.92 ± 2.16

0.089
0.053
0.564

0.754
0.0001
0.345

0.001
0.0001
0.0001

0.675
0.012
0.654
Degree of control on anti-diabetic treatment
Controlled; # (%)
Uncontrolled; # (%)
Degree of control on anti-hypertensive treatment
Controlled; # (%)
Uncontrolled; # (%)
Degree of control on lipid lowering treatment
Controlled; # (%)
Uncontrolled; # (%)

12 (48%)
13 (52%)

10 (40%)
15 (60%)

12 (48%)
13 (52%)

3 (30%)
7 (70%)

0
10 (100%)

3 (30%)
7 (70%)

12 (57.14%)
9 (42.86%)

5 (23.81%)
16 (76.19%)

12 (57.14%)
9 (42.86%)

3 (5%)
1 (1.67%)

2 (3.33%)
2 (3.33%)

4 (6.67%)
0

-
-

-
-

-
-

-
-

-
-

-
-

-
-

-
-

-
-

-
-

-
-

-
-
Data are expressed as mean � SD; number (%)
MoA, migraine without aura; MA, migraine with aura; BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure Significance: P1: MoA versus TTH; P2: MA versus TTH; P3: chronic migraine versus TTH; P4: MoA versus MA; P5: MoA versus chronic migraine; P6: MA versus chronicmigraine
Table 3: Demographic, anthropometric and clinical characteristics of the studied groups according to the type of headache.